StockData
Charles River Laboratories International, Inc. logo

Charles River Laboratories International, Inc. (CRL) stock

CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30225% above fair value
$332.16−3.36 (-1.00%)

Close on Nov 17, 2026Market cap $15.86BP/E –Yield –

Charles River Laboratories International operating margin

Operating margin is operating income as a percentage of revenue.

Charles River Laboratories International's operating margin for the twelve months ending Jun 27, 2026 was 2.3%. For fiscal 2025 it was 0.6%, against 5.6% the year before. The highest annual figure on record is 16.7% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 27, 20250.6%−5.0
FY2024Dec 28, 20245.6%−9.3
FY2023Dec 30, 202314.9%−1.4
FY2022Dec 31, 202216.4%−0.3
FY2021Dec 25, 202116.7%+1.9
FY2020Dec 26, 202014.8%+1.4
FY2019Dec 28, 201913.4%−1.2
FY2018Dec 29, 201814.6%−0.9
FY2017Dec 30, 201715.5%+1.4
FY2016Dec 31, 201614.1%−1.0
FY2015Dec 26, 201515.1%+1.5
FY2014Dec 27, 201413.7%+0.7
FY2013Dec 28, 201313.0%−1.7
FY2012Dec 29, 201214.7%−0.6
FY2011Dec 31, 201115.3%+41.6
FY2010Dec 25, 2010-26.3%−40.8
FY2009Dec 26, 200914.5%+49.4
FY2008Dec 27, 2008-34.9%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 27, 202611.9%+2.2
Q1 FY2026Mar 28, 202612.0%+4.5
Q4 FY2025Dec 27, 2025-28.5%−11.8
Q3 FY2025Sep 27, 202513.3%+1.7
Q2 FY2025Jun 28, 20259.7%−5.1
Q1 FY2025Mar 29, 20257.6%−4.9
Q4 FY2024Dec 28, 2024-16.7%−29.8
Q3 FY2024Sep 28, 202411.6%−3.1
Q2 FY2024Jun 29, 202414.8%−0.8
Q1 FY2024Mar 30, 202412.5%−3.9
Q4 FY2023Dec 30, 202313.1%−1.8
Q3 FY2023Sep 30, 202314.8%−0.5
Q2 FY2023Jul 1, 202315.6%−3.7
Q1 FY2023Apr 1, 202316.3%+0.0
Q4 FY2022Dec 31, 202214.9%−4.2
Q3 FY2022Sep 24, 202215.3%−2.1
Q2 FY2022Jun 25, 202219.3%+4.2
Q1 FY2022Mar 26, 202216.3%+1.3
Q4 FY2021Dec 25, 202119.1%+2.8
Q3 FY2021Sep 25, 202117.4%−0.5
Q2 FY2021Jun 26, 202115.0%+3.8
Q1 FY2021Mar 27, 202115.0%+1.7
Q4 FY2020Dec 26, 202016.3%+0.6
Q3 FY2020Sep 26, 202017.9%+4.0
Q2 FY2020Jun 27, 202011.2%−0.9
Q1 FY2020Mar 28, 202013.3%+1.8
Q4 FY2019Dec 28, 201915.7%−1.3
Q3 FY2019Sep 28, 201913.9%−0.5
Q2 FY2019Jun 29, 201912.1%−1.0
Q1 FY2019Mar 30, 201911.5%−2.2
Q4 FY2018Dec 29, 201817.0%+3.9
Q3 FY2018Sep 29, 201814.4%−1.5
Q2 FY2018Jun 30, 201813.1%−4.3
Q1 FY2018Mar 31, 201813.7%−1.9
Q4 FY2017Dec 30, 201713.1%−1.7
Q3 FY2017Sep 30, 201716.0%+2.1
Q2 FY2017Jul 1, 201717.4%–
Q1 FY2017Apr 1, 201715.6%–
Q4 FY2016Dec 31, 201614.8%–
Q3 FY2016Sep 24, 201613.8%–

More Charles River Laboratories International figures

See a number that looks wrong?